금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Fed Chair Warsh will be in the hot seat as lawmakers press for his read on the economy
Kevin Warsh will testify before Congress for the first time as Fed chair this week. Lawmakers will w...
The June jobs report laid an egg: The US only added roughly half of what economists had forecast — what it means for you
Payrolls badly missed the 115,000 economists expected, and the unemployment rate's dip to 4.2% maske...
Oil Prices Are Plunging, but Trumpflation Is Getting Worse -- Here's Why
Trumpflation has entered a new phase, which is terrible news for consumers and the stock market....
3 Reasons to Avoid ACI and 1 Stock to Buy Instead
Over the past six months, Albertsons’s stock price fell to $14.12. Shareholders have lost 18.9% of their capital, which is disappointing considering the S&P 500 has climbed by 6.3%. This might have in ...
Traders discount a higher bid coming in on Caesars Entertainment
First Trust International Developed Capital Strength ETF declares quarterly distribution of $0.4455
Will the Vanguard S&P 500 ETF Invest in SpaceX Stock? It's Complicated.
SpaceX could be coming to your S&P 500 ETF -- eventually.
Healthcare and data center REITs dominate real estate growth rankings
3 Reasons to Avoid PII and 1 Stock to Buy Instead
Polaris has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 7.3% to $71.06 per share while the index has gained 6.3%.
How To Validate Stock Market Ideas With The IBD Stock Checklist
Stock market leader Marvell Technology gets a lot of green in the IBD Stock Checklist due to strong fundamentals and price performance.
Update: Equity Markets Mixed Intraday as Apple Falls, Micron Rallies
(Updates with latest market prices and developments.) US benchmark equity indexes were mixed intr
ICU Medical (ICUI): Buy, Sell, or Hold Post Q1 Earnings?
ICU Medical has been treading water for the past six months, recording a small loss of 3.3% while holding steady at $142.98. The stock also fell short of the S&P 500’s 6.3% gain during that period.
Palantir's selloff continues, marking the seventh straight session of declines
Record-setting healthcare M&A activity to extend through H2: PwC
First Trust Dividend Strength ETF declares quarterly distribution of $0.1928